Skip to main content
Aditya Bagrodia, MD, Urology, La Jolla, CA

AdityaBagrodiaMD

Urology La Jolla, CA

Surgical Oncology

Associate Professor and Disease Team Co-Leader for Genitourinary Oncology

Dr. Bagrodia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bagrodia's full profile

Already have an account?

  • Office

    9400 Campus Point Dr
    La Jolla, CA 92037
    Phone+1 858-657-7876
    Fax+1 858-249-3850

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2014 - 2016
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Urology, 2010 - 2014
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterInternship, Transitional Year, 2009 - 2010
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2009
  • Rhodes College
    Rhodes CollegeB.S., Biology, Minor in Religious Studies, 2000 - 2004

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2016 - 2026
  • CA State Medical License
    CA State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2014 - 2017
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Dedman Family Scholar in Clinical Care UTSW, 2016
  • AUA Urology Care Foundation Research Scholars Grant MSKCC, 2015
  • Merit award and oral abstract GU ASCO, MSKCC, 2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clonal Relatedness and Mutational Differences Between Upper Tract and Bladder Urothelial Carcinoma  
    Aditya Bagrodia, Paari Murugan, Clinical Cancer Research
  • Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?  
    Krabbe LM, Bagrodia A, Westerman ME, Gayed BA, Haddad AQ, Sagalowsky AI, et al., World J Urol, 1/1/2016
  • Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma  
    Li Q, Bagrodia A, Cha EK, Coleman JA, Current urology reports, 1/1/2016
  • Join now to see all

Authored Content

  • Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
  • Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
  • Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018

Press Mentions

  • Prostate Cancer Treatments Can Be Avoided or Delayed in Many Cases, Study Finds
    Prostate Cancer Treatments Can Be Avoided or Delayed in Many Cases, Study FindsMarch 15th, 2023
  • UT Southwestern Levels the Playing Field for Testicular Cancer Patients
    UT Southwestern Levels the Playing Field for Testicular Cancer PatientsAugust 10th, 2020
  • Testicular Cancer a Bigger Threat to Young Men
    Testicular Cancer a Bigger Threat to Young MenJanuary 3rd, 2019
  • Join now to see all